CNX
42
4
GILD
54
-2
VZ
45
3
CSX
44
-6
CTSH
57
-2
DRI
53
-4
UA
51
10
BF.B
36
3
AAP
8
2
KSS
52
-3
JBHT
58
-5
PSA
38
3
NOC
54
-3
EQIX
67
2
TJX
51
-4
BLK
58
-3
D
43
-2
HCA
62
-2
CRM
57
-2
TROW
56
-3
CNX
42
4
GILD
54
-2
VZ
45
3
CSX
44
-6
CTSH
57
-2
DRI
53
-4
UA
51
10
BF.B
36
3
AAP
8
2
KSS
52
-3
JBHT
58
-5
PSA
38
3
NOC
54
-3
EQIX
67
2
TJX
51
-4
BLK
58
-3
D
43
-2
HCA
62
-2
CRM
57
-2
TROW
56
-3
Financhill
Back

The Allstate Corp. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison

Buy
57

ALL
The Allstate Corp.

Last Price:
$208.18
Seasonality Move:
1.7%
Sell
41

ALNY
Alnylam Pharmaceuticals, Inc.

Last Price:
$397.66
Seasonality Move:
0.84%
Buy
57
The Allstate Corp. (ALL) is a Buy

Is The Allstate Corp. a Buy, Sell or Hold?

  • The current The Allstate Corp. [ALL] share price is $208.15. The Score for ALL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ALL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.65. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALL Stock Price Chart

What is The Allstate Corp.'s stock price today?

  • The The Allstate Corp. share price today is $208.15
    The current trend is moderately bullish and ALL is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals, Inc.'s stock price today?

  • The Alnylam Pharmaceuticals, Inc. share price today is $397.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

ALL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 51.91 Buy
Chaikin Money Flow: -761026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (204.23 - 211.27) Buy
Bollinger Bands (100): (198.57 - 211.31) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.2 Sell
Relative Strength Index (14 RSI): 37.79 Sell
Chaikin Money Flow: -650289 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (391.88 - 446.1) Sell
Bollinger Bands (100): (422.72 - 470.24) Sell

ALL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 208.2 Sell
20-day SMA: 206.77 Buy
50-day SMA: 204.45 Buy
200-day SMA: 202.3 Buy
8-day EMA: 208.26 Sell
20-day EMA: 207.69 Buy
50-day EMA: 206.25 Buy
200-day EMA: 201.04 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 400.21 Sell
20-day SMA: 411.45 Sell
50-day SMA: 436.15 Sell
200-day SMA: 371.13 Buy
8-day EMA: 399.81 Sell
20-day EMA: 410 Sell
50-day EMA: 426.22 Sell
200-day EMA: 383.9 Buy

The Allstate Corp. Earnings Growth & ALL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.93 per share, and an increase next year of $0.19 per share.

Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.

The Allstate Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):